Silver Book Fact

Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population

Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. European Heart Journal. 2016; 34(47). https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehw229

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Aortic stenosis impacts majority of heart valve disease patients
    Aortic stenosis (AS) is among the most common forms of heart valve disease (HVD), affecting 2% to 3% of the adult U.S. population.  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.  
  • Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.
     
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.